Association of CYP3A5FNx013 polymorphism with development of acute leukemia
D. Surekha
Indian Journal of Human Genetics, 2011
View PDFchevron_right
CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia
Jeremy Mills
Current Cancer Drug Targets, 2020
View PDFchevron_right
The impact of genetic polymorphisms of cytochrome P450 (CYP1A1&2D6) gene in the incidence of acute myeloid leukaemia
Jeremy Mills
Pakistani Journal of Medical and Health Sciences, 2020
View PDFchevron_right
Increased Risk for Acute Lymphoblastic Leukemia in Children with Cytochrome P450 A1(CYP1A1)- and NAD(P)H:Quinone Oxidoreductase 1 (NQO1)-Inherited Gene Variants
Carmen Lima
Acta Haematologica, 2010
View PDFchevron_right
Association of CYP2D6* 4 Polymorphism with Chronic Myeloid Leukemia
D. Surekha, Vishnupriya Satti
Journal of Medical …, 2007
View PDFchevron_right
Association of CYP3A5*3 and CYP1A1*2C Polymorphism with Development of Acute Myeloid Leukemia in Egyptian Patients
Sherin Taha
Asian Pacific journal of cancer prevention : APJCP, 2017
View PDFchevron_right
Distribution of CYP1A1⁎2A polymorphism in adult patients with acute lymphoblastic leukemia in a Mexican population
Luis Figuera
Blood Cells Molecules and Diseases, 2008
View PDFchevron_right
CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia
Avital Cnaan
British Journal of Haematology, 2003
View PDFchevron_right
High risk of ‘de novo’ acute myeloid leukaemia in individuals with cytochrome P450 A1 ( CYP1A1 ) and NAD(P)H:quinone oxidoreductase 1 ( NQO1 ) gene defects
Carmen Lima
European Journal of Haematology, 2009
View PDFchevron_right
Frequency and prognostic significant of CYP3A4-A-290G polymorphism in acute myeloid leukemia
Nevin M. Al-Azhary
Frequency and prognostic significant of CYP3A4-A-290G polymorphism in acute myeloid leukemia, 2013
View PDFchevron_right
GENETIC LINKED TO LEUKEMIA: ROLE OF POLYMORPHISMS IN CANDIDATE GENES INTERCONNECTED TO LEUKEMIA
ali hussein
View PDFchevron_right
CYP2C19 genotypes in a population of healthy volunteers and in children with hematological malignancies in Gaza Strip
Fadel A Sharif
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique
View PDFchevron_right
Genetic Polymorphism of Metabolic Enzymes P450 (CYP) as a Susceptibility Factor for Drug Response, Toxicity, and Cancer Risk
Mila Lovrić
Archives of Industrial Hygiene and Toxicology, 2009
View PDFchevron_right
CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukemia
asuman sunguroglu
Swiss medical weekly, 2008
View PDFchevron_right
Cytochrome P450 1A1 genetic polymorphisms as cancer biomarkers
Niladri Bag
Indian Journal of Cancer, 2015
View PDFchevron_right
Impact of Cytochromes P450 3A4 and 2B6 gene polymorphisms on predisposition and prognosis of acute myeloid leukemia: an Egyptian case-control study
Shahira Botros
Egyptian Journal of Medical Human Genetics, 2021
View PDFchevron_right
CYP3A4*18 and CYP3A5*3 Polymorphisms in Modulating Susceptibility Risk in Malaysian Chronic Myeloid Leukaemia Patients
RAVINDRAN ANKATHIL
Archives of Orofacial Sciences, 2020
View PDFchevron_right
CYP3A gene variability and cancer cells response to the treatment
Lenka Maliničová
General Physiology and Biophysics, 2021
View PDFchevron_right
Association of The Common CYP1A1*2C Variant (Ile462Val Polymorphism) with Chronic Myeloid Leukemia (CML) in Patients Undergoing Imatinib Therapy
Lakkireddy Samyuktha
Cell journal, 2015
View PDFchevron_right
Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response
Sunishtha Singh Yadav
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2010
View PDFchevron_right
Genetic Polymorphism in Cytochrome P450 1B1 in a Spanish Population
Blanca Laffon
Basic & Clinical Pharmacology & Toxicology, 2007
View PDFchevron_right
Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention
William Figg
Molecular Cancer Research, 2006
View PDFchevron_right
CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome
Rosane Queiroz
Molecular and Cellular Biochemistry, 2012
View PDFchevron_right
Ancestry and pharmacogenetics of antileukemic drug toxicity
Tony Frudakis
Blood, 2007
View PDFchevron_right
Cytochrome P450 1B1 Gene Polymorphisms as Predictors of Anticancer Drug Activity: Studies with In vitro Models
Jacques Robert
Molecular Cancer Therapeutics, 2010
View PDFchevron_right
Impact of CYP3A5 Genetic Polymorphism on the Biotransformation of Drugs and Environmental Toxins
Landry Kamdem
2006
View PDFchevron_right
Polymorphisms of the CYP1A1, CYP2E1 and XRCC1 genes and cancer risk in a Southern Italian population: a case-control study
vitina grieco
Anticancer research, 2011
View PDFchevron_right